Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10353 in Postpartum Depression
NCT05937867Phase 2Not yet recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Aug 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of HS-10353 in postpartum depression (PPD), sponsored by Hansoh Pharmaceutical Group. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
HS-10353
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT05937867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05937867.